Retractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a research report issued to clients and investors on Thursday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Price Performance

Shares of RVP stock opened at $1.07 on Thursday. The stock has a 50 day moving average of $1.18 and a two-hundred day moving average of $1.16. The company has a current ratio of 8.28, a quick ratio of 6.41 and a debt-to-equity ratio of 0.01. Retractable Technologies has a 12 month low of $0.95 and a 12 month high of $1.85. The company has a market capitalization of $32.04 million, a P/E ratio of -4.46 and a beta of 2.11.

Hedge Funds Weigh In On Retractable Technologies

An institutional investor recently raised its position in Retractable Technologies stock. WealthTrust Axiom LLC increased its stake in shares of Retractable Technologies, Inc. (NYSE:RVP) by 27.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 126,533 shares of the company’s stock after buying an additional 27,500 shares during the quarter. WealthTrust Axiom LLC owned 0.42% of Retractable Technologies worth $151,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.